ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,402.90
0.66%
S&P ASX All Technology
3,834.70
0.92%
Brent Oil
79.325
0.13%
US Dollar vs AUD
1.60024
0.51%
Bitcoin
102,577.06
0.54%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Eupraxia Pharmaceuticals Inc (EPRX) Share Price

Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc (EPRX)

Eupraxia Pharmaceuticals Inc
3.20
0.19
(6.31%)
Closed 21 January 8:00AM
Delayed by 15 minutes
3.20
0.00
(0.00%)
After Hours: 9:43AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
3.20
Bid
3.02
Offer
4.84
Volume
583
3.09 Day's Range 3.20
2.20 52 Week Range 4.08
Market Cap
113.992M
Previous Close
3.01
Open
3.09
Last Trade
1
@
3.01
Last Trade Time
Financial Volume
US$ 1,866
VWAP
3.20
Average Volume (3m)
17,312
Shares Outstanding
35,622,553
Dividend Yield
-
PE Ratio
-5.86
Earnings Per Share (EPS)
-0.79
Revenue
-
Net Profit
-28.22M

About Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient be... Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.eupraxiapharma.com
Headquarters
Victoria, British Columbia, Can
Founded
-
Eupraxia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EPRX. The last closing price for Eupraxia Pharmaceuticals was US$3.01. Over the last year, Eupraxia Pharmaceuticals shares have traded in a share price range of US$ 2.20 to US$ 4.08.

Eupraxia Pharmaceuticals currently has 35,622,553 shares in issue. The market capitalisation of Eupraxia Pharmaceuticals is US$107.22 million. Eupraxia Pharmaceuticals has a price to earnings ratio (PE ratio) of -5.86.

Ask ADVFN Intelligence (AI)

EPRX Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

21 November 2024
Edgar (US Regulatory)

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months PR Newswire VICTORIA, BC, Nov. 20, 2024...

20 November 2024
PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

15 November 2024
Edgar (US Regulatory)

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting

Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting PR Newswire VICTORIA, BC, Nov. 14, 2024 VICTORIA, BC, Nov. 14, 2024 /PRNewswire/ - Eupraxia...

15 November 2024
PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

14 November 2024
Edgar (US Regulatory)

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November 15, 2024

Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November...

14 November 2024
PR Newswire (Canada)

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis Canada NewsWire VICTORIA, BC, Nov. 12, 2024...

13 November 2024
PR Newswire (Canada)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.26.6666666666733.22.8490183.06774367CS
40.12584.092121527553.07423.232.7563313.08675398CS
120.7329.55465587042.474.082.326173123.27878547CS
260.5219.40298507462.684.082.2117663.04188972CS
52-0.35-9.859154929583.554.082.2153032.93897157CS
156-0.35-9.859154929583.554.082.2153032.93897157CS
260-0.35-9.859154929583.554.082.2153032.93897157CS

EPRX - Frequently Asked Questions (FAQ)

What is the current Eupraxia Pharmaceuticals share price?
The current share price of Eupraxia Pharmaceuticals is US$ 3.20
How many Eupraxia Pharmaceuticals shares are in issue?
Eupraxia Pharmaceuticals has 35,622,553 shares in issue
What is the market cap of Eupraxia Pharmaceuticals?
The market capitalisation of Eupraxia Pharmaceuticals is USD 107.22M
What is the 1 year trading range for Eupraxia Pharmaceuticals share price?
Eupraxia Pharmaceuticals has traded in the range of US$ 2.20 to US$ 4.08 during the past year
What is the PE ratio of Eupraxia Pharmaceuticals?
The price to earnings ratio of Eupraxia Pharmaceuticals is -5.86
What is the reporting currency for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals reports financial results in USD
What is the latest annual profit for Eupraxia Pharmaceuticals?
The latest annual profit of Eupraxia Pharmaceuticals is USD -28.22M
What is the registered address of Eupraxia Pharmaceuticals?
The registered address for Eupraxia Pharmaceuticals is 201 - 2067 CADBORO BAY ROAD, VICTORIA, BRITISH COLUMBIA, V8R 5G4.
What is the Eupraxia Pharmaceuticals website address?
The website address for Eupraxia Pharmaceuticals is www.eupraxiapharma.com
Which industry sector does Eupraxia Pharmaceuticals operate in?
Eupraxia Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

Discussion

View Full Feed
StayHumble StayHumble 2 minutes ago
Yes💹LOTS of SHORT interest💹Squeeze Incoming💹💹💹

"....Naked Shorts say what?........Xactly......"
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
HIRU
fuagf fuagf 3 minutes ago
LOL Understand them well, just the questions should be put to them.
Zorax Zorax 4 minutes ago
What's sad is it won't stop anything fb already tracks.
And fb is still tracking you no matter what you do in your 'personal' settings. To believe you've stopped all fb tracking is naive.
Where you went sends fb data anyways. Thing is, what are you going to do about it? Sue him? Send i
jimr1717 jimr1717 6 minutes ago
If EGOmike is pumping you better be dumping.
BIXT
StayHumble StayHumble 6 minutes ago
GreenAcres acquisition launch💹 $HCWC AnnualRevenue $75Million+💹 @healthiercmc
https://www.healthiercmc.com/news/2024/7/24/hcmc-announces-the-acquisition-of-greenacres-market-with-5-stores-located-in-kansas-and-oklahoma


https://static1.squarespace.com/sta
HCWC
fuagf fuagf 6 minutes ago
Zorax, How about slipping in the odd link to expand on the info you give us. I don't doubt it as most every time i've gone after more all you say is basically true. It's just that i'd really appreciate more information about most all of your wortwhile insights. Just one or two each time of the many
StayHumble StayHumble 7 minutes ago
💹 💹wow Jury Trial Incoming wow💹 💹 💹 💹 💹 People Matter wow
HCMC
jimr1717 jimr1717 8 minutes ago
If EGOmike is pumping you better be dumping.
NFTM
Adamph85 Adamph85 9 minutes ago
No no no, it looks EPIC. We're heading to DOLLARS 💸
TMMI
StayHumble StayHumble 10 minutes ago
💹95M+ XPERT .000001 BUYS💹insider BUYBACK Ongoing💹💹 https://ih.advfn.com/stock-market/USOTC/healthier-choices-manage-pk-HCMC/trades 💹
HCMC
dinogreeves dinogreeves 10 minutes ago
Of course he will give you his number, Stervc has never bought a stock in the National Exchange, he front loads and expects you to call him and plays music to your ears, except he stutters a lot, "and" "and" lot of "and" tells you what you want to hear, so him and his friends who front loaded can se
TWOH
mutant mutant 10 minutes ago
Dear friends on the uwbkq board, sorry for the links being diplayed, and ignore the yellow highlight . I hope you are well. Docsavag, question, you dont have to answer in writing, from a moderators view point, is this post deplorable and not worthy of this board. The following is completely fictiona
FFRXQWDQW SSOLFDWLRQ
BDEZ BDEZ 11 minutes ago
Anti-Trump protestors are starting to make a scene at the jail where the J6 hostages will be released

https://x.com/TaraBull808/status/1881536542872940818
jimr1717 jimr1717 12 minutes ago
If EGOmike is pumping you better be dumping.
IFUS
StayHumble StayHumble 13 minutes ago
inCourt UnderOath💹SEC triedBashing $DBMM+Mgmt💹(D0H! Br. at 25-28.)

$DBMM has obtained resources to complete the re-audit, bring the Company current, & continue its timely filings,

DOE once again rejects the Law Judge’s analysis and conclusion that
DBMM
boi568 boi568 15 minutes ago
Correct, guidance is not a regulation. But this is the kind of guidance that has been published in the Federal Register, and the freeze is going to shut down this type of FR publications for a while.
AVXL
FNM500K FNM500K 16 minutes ago
Still here and still negative for all these years?? Probably time to sell and exit. Think about it.
FNMA
PEACHMAN PEACHMAN 17 minutes ago
https://investorshub.advfn.com/uimage/uploads/2025/1/20/qieixfrjueKeanu_Reeves.jpg
IFUS
janice shell janice shell 17 minutes ago
Yes, that's just hilarious.
boi568 boi568 17 minutes ago
I predicted a regulatory freeze on November 29th, post 475631. Thanks for asking.

Now, I also said I expected the FDA would beat that deadline, but it looks now like they haven't. That was always a possibility. The chance of no regulatory freeze was much lower.
AVXL
Juntao Juntao 18 minutes ago
ENAB
arizona1 arizona1 18 minutes ago
On what basis do you still trust him.

You simply don't understand the cult mentality. Nothing he could ever do would possibly question their undying loyalty. They still believe he cancelled his outdoor inauguration because it was cold.
shajandr shajandr 18 minutes ago
Odds and Ends:

1. Musk's reporting violation is similar to a jaywalking ticket. I agree with 1manband that it is a valid citation for a clear, unexcused violation.

2. I would point ~OUTT that most of us know that reporting violations are common, and especially so in pen
OMOLIVES OMOLIVES 18 minutes ago
lol...it aint' what it used to be and it's a shame. I hear ya'
DROR

Your Recent History

NASDAQ
EPRX
Eupraxia Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads